PMID- 29299040 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240327 IS - 1743-7075 (Print) IS - 1743-7075 (Electronic) IS - 1743-7075 (Linking) VI - 14 DP - 2017 TI - The metabolism and significance of homocysteine in nutrition and health. PG - 78 LID - 10.1186/s12986-017-0233-z [doi] LID - 78 AB - An association between arteriosclerosis and homocysteine (Hcy) was first demonstrated in 1969. Hcy is a sulfur containing amino acid derived from the essential amino acid methionine (Met). Hyperhomocysteinemia (HHcy) was subsequently shown in several age-related pathologies such as osteoporosis, Alzheimer's disease, Parkinson's disease, stroke, and cardiovascular disease (CVD). Also, Hcy is associated with (but not limited to) cancer, aortic aneurysm, hypothyroidism and end renal stage disease to mention some. The circulating levels of Hcy can be increased by defects in enzymes of the metabolism of Met, deficiencies of vitamins B(6), B(12) and folate or by feeding Met enriched diets. Additionally, some of the pharmaceuticals currently in clinical practice such as lipid lowering, and anti-Parkinsonian drugs are known to elevate Hcy levels. Studies on supplementation with folate, vitamins B(6) and B(12) have shown reduction in Hcy levels but concomitant reduction in certain associated pathologies have not been definitive. The enormous importance of Hcy in health and disease is illustrated by its prevalence in the medical literature (e.g. > 22,000 publications). Although there are compelling data in favor of Hcy as a modifiable risk factor, the debate regarding the significance of Hcy mediated health effects is still ongoing. Despite associations between increased levels of Hcy with several pathologies being well documented, whether it is a causative factor, or an effect remains inconclusive. The present review though not exhaustive, is focused on several important aspects of Hcy metabolism and their relevance to health. FAU - Kumar, Avinash AU - Kumar A AD - Environmental Toxicology Department, Southern University and A&M College, Baton Rouge, LA 70813 USA. ISNI: 0000 0004 0386 0655. GRID: grid.263880.7 FAU - Palfrey, Henry A AU - Palfrey HA AD - Environmental Toxicology Department, Southern University and A&M College, Baton Rouge, LA 70813 USA. ISNI: 0000 0004 0386 0655. GRID: grid.263880.7 FAU - Pathak, Rashmi AU - Pathak R AD - Environmental Toxicology Department, Southern University and A&M College, Baton Rouge, LA 70813 USA. ISNI: 0000 0004 0386 0655. GRID: grid.263880.7 FAU - Kadowitz, Philip J AU - Kadowitz PJ AD - Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA USA. ISNI: 0000 0001 2217 8588. GRID: grid.265219.b FAU - Gettys, Thomas W AU - Gettys TW AD - Laboratory of Nutrient Sensing and Adipocyte Signaling, Pennington Biomedical Research Center, Baton Rouge, LA USA. ISNI: 0000 0001 2159 6024. GRID: grid.250514.7 FAU - Murthy, Subramanyam N AU - Murthy SN AUID- ORCID: 0000-0002-9337-329X AD - Environmental Toxicology Department, Southern University and A&M College, Baton Rouge, LA 70813 USA. ISNI: 0000 0004 0386 0655. GRID: grid.263880.7 LA - eng PT - Journal Article PT - Review DEP - 20171222 PL - England TA - Nutr Metab (Lond) JT - Nutrition & metabolism JID - 101231644 PMC - PMC5741875 OTO - NOTNLM OT - Cardiovascular disease OT - Dietary OT - Homocysteine OT - Hyperhomocysteinemia OT - Inflammation OT - Methionine COIS- Not Applicable.Not Applicable.None of the authors have any competing interest.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2018/01/05 06:00 MHDA- 2018/01/05 06:01 PMCR- 2017/12/22 CRDT- 2018/01/05 06:00 PHST- 2017/11/10 00:00 [received] PHST- 2017/12/07 00:00 [accepted] PHST- 2018/01/05 06:00 [entrez] PHST- 2018/01/05 06:00 [pubmed] PHST- 2018/01/05 06:01 [medline] PHST- 2017/12/22 00:00 [pmc-release] AID - 233 [pii] AID - 10.1186/s12986-017-0233-z [doi] PST - epublish SO - Nutr Metab (Lond). 2017 Dec 22;14:78. doi: 10.1186/s12986-017-0233-z. eCollection 2017.